BETADINE (povidone-iodine) by Alcon is clinical pharmacology: a placebo-controlled study in 38 normal volunteers yielded data for 36 subjects who showed a mean log10 reduction of 3. First approved in 1986.
Drug data last refreshed 14h ago · AI intelligence enriched 1mo ago
BETADINE (povidone-iodine 5%) is a broad-spectrum antiseptic solution administered as ophthalmic drops for preoperative skin preparation and infection prevention in eye surgery. It works by releasing iodine, which denatures bacterial proteins and rapidly reduces aerobic bacterial load by 3+ log10 units within 10 minutes. The product is indicated for ocular surface antisepsis in surgical settings.
Minimal commercial spending and claim volume signal a mature, low-volume specialty product with limited growth potential for sales and marketing teams.
CLINICAL PHARMACOLOGY: A placebo-controlled study in 38 normal volunteers yielded data for 36 subjects who showed a mean log10 reduction of 3.05 log10 units in total aerobes at 10 minutes following prepping the skin with BETADINE* 5% Sterile Ophthalmic Prep Solution compared with reduction of 1.58…
Antiseptic
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
SURGX Antimicrobial Gel Versus Povidone-iodine Skin Incision Prep in Total Shoulder Arthroplasty
Treatment of Adenoviral Conjunctivitis With SHP640 Compared to Povidone-iodine (PVP-I) and Placebo
Betadine Irrigation in Cesarean Section
Prevention of Surgical Site Infections: Effectiveness of Nasal Povidone-Iodine and Nasal Mupirocin
Povidone-iodine Antisepsis for Strabismus Surgery
Worked on BETADINE at Alcon? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Upgrade to Pro to access Medicare Part D spending data and other premium pharma intelligence.
Upgrade to Pro — $25/moBETADINE offers limited career growth given its mature LOE stage, minimal spending, and low job posting count; roles would focus on generic defense, supply chain optimization, and specialty ophthalmic channel management rather than innovation. Positions on this product are typically maintenance-focused with low visibility for career advancement into larger franchises.